News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Omar A. Zayas-Villanueva

Articles by Omar A. Zayas-Villanueva

108 Long-Term Safety and Efficacy of First-Line Next Generation CDK4-Selective Inhibitor Atirmociclib + Letrozole for the Treatment of Patients With HR+/HER2− Metastatic Breast Cancer

ByTimothy A. Yap, MBBS, PhD, FRCP,Manuel Magallanes,Binghe Xu,Diego Lucas Kaen,Ernesto Pablo Korbenfeld,Min Yan,Omar A. Zayas-Villanueva,Carlos Alberto Hernández,Peter Schmid, MD,Michal Mego,Santiago Rafael Bella,Xinhong Wu,Madeena Siddiqui,Cynthia Basu,Jennifer Park,Jason Gong,Antonio Giordano

May 17th 2026

Latest Updated Articles

Trending on CancerNetwork

Yoga Could Alter Cancer-Related Fatigue Levels Across Solid Tumors

109 Extended Adjuvant Neratinib in HER2+/HR+ Early Breast Cancer in Clinical Routine: Final Results from the Multi-national, Prospective, Observational Study ELEANOR

FDA Approves Atezolizumab in MIBC Post-Cystectomy with ctDNA MRD

Identifying Psychoneurological Symptom Clusters in Heme Malignancies

How Might CAR T Cells and Bispecifics Evolve in Multiple Myeloma Therapy?